Calpain-5 Peptide Substrates for Precise Activity Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for new therapies to treat intraocular inflammation, particularly for conditions like autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV), which is characterized by retinal synaptic signaling defects and retinal neovascularization, and is caused by calpain-5 hyperactivity.
Innovation Solution
Development of novel peptide substrates and inhibitors for calpain-5, including specific amino acid sequences and detectable labels, to measure and inhibit calpain-5 activity, with methods for screening candidate agents and treating associated retinal diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional assays are used to measure calpain-5 activity, then the measurement process is simple, but the precision and reliability of calpain-5 activity measurement is insufficient
Solution Approach 1:
The patent introduces peptide substrates as intermediary molecules that specifically interact with calpain-5. These substrates contain detectable labels and are designed to be cleaved by calpain-5, converting the complex enzymatic activity measurement into a detectable signal change. This intermediary approach enables precise measurement of calpain-5 activity while maintaining assay simplicity.
Solution Approach 2:
The patent modifies the measurement parameters by using peptide substrates with specific amino acid sequences and detectable labels. By changing the substrate structure and incorporating labels that produce detectable signals (such as fluorescence or colorimetric changes), the assay achieves higher precision in measuring calpain-5 activity without requiring complex instrumentation.
2Reliability
If no specific inhibitors are used, then the therapeutic approach is general, but the effectiveness in reducing calpain-5-mediated inflammation is insufficient
Solution Approach 1:
The patent develops inhibitors with specific local properties - particular amino acid sequences and structural features that target calpain-5 specifically. These inhibitors are designed to interact with specific regions of the calpain-5 enzyme, providing localized and specific inhibition. This approach ensures high therapeutic effectiveness in reducing calpain-5-mediated inflammation while maintaining selectivity for the target enzyme.
Solution Approach 2:
The patent uses peptide substrates as templates to design inhibitors. By analyzing the sequence and structure of substrates that bind to calpain-5, researchers can create inhibitor copies with modified structures that block enzyme activity. This copying approach allows development of specific inhibitors based on known substrate-enzyme interactions, improving therapeutic reliability.
3Measurement precision
If existing peptide substrates are used, then the assay protocol is straightforward, but the ability to detect and measure calpain-5 activity accurately is limited
Solution Approach 1:
The patent replaces complex mechanical or instrumental measurement systems with chemical-biological detection methods. By incorporating detectable labels into peptide substrates that produce measurable signals (fluorescence, colorimetric changes) upon enzymatic cleavage, the assay achieves high detection accuracy without requiring sophisticated equipment. This substitution simplifies the overall measurement system while improving precision.
Solution Approach 2:
The patent creates composite peptide substrates that combine multiple functional elements: specific amino acid sequences for enzyme recognition, detectable labels for signal generation, and structural features for stability. These composite materials integrate multiple functions into a single molecule, enabling accurate detection of calpain-5 activity while maintaining ease of assay performance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel peptide substrates and inhibitors effectively assess and reduce calpain-5-mediated inflammation, providing potential therapeutic agents for treating retinal diseases and other conditions associated with calpain-5 hyperactivity.
Implementation Method 1
the peptide serves as a substrate and is capable of undergoing proteolytic cleavage by calpain-5
Implementation Method 2
labeled with a fluorescent donor and acceptor pair (e.g., with spacing suitable for a fluorescence resonance energy transfer (FRET) assay)
Data Source
AI summary
Compositions, methods, and kits are provided for assaying calpain-5 activity and inhibition. In particular, novel peptide substrates are provided for detecting calpain-5, measuring calpain-5 activity, and screening for inhibitors of calpain-5 to identify potential therapeutic agents for treating retinal diseases and other diseases associated with calpain-5 hyperactivity. Additionally, novel inhibitors of calpain-5 are also provided.